Characterization of the UDP-glucuronosyltransferases involved in the glucuronidation of an antithrombotic thioxyloside in rat and humans

Drug Metabolism and Disposition

Volumn 27, Issue 5, 1999, Pages 588-595

  Pless, Dorothy ^a   Gouze, Jean Noel ^a   Senay, Claire ^a   Herber, Regine ^b   Leroy, Pierre ^a   Barberousse, Veronique ^c   Fournel Gigleux, Sylvie ^a   Magdalou, Jacques ^a,d  

^a UNIVERSITÉ DE LORRAINE   (France)

^b Centre du Medicament URA CNRS 597   (France)

^c Laboratoires Fournier   (France)

^d Tecnologia Avanzada   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; ANTICOAGULANT AGENT; BECIPARCIL; CLOFIBRATE; GLUCURONOSYLTRANSFERASE; PHENOBARBITAL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME MECHANISM; HUMAN; HUMAN TISSUE; ISOMER; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 0032931048     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bradford MM (1976) A rapid and sensitive method for quantification of micrograms of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
2. Castle MC (1993) Formation of a β-glucuronidase-resistant glucuronide conjugate of digitoxin by dog liver microsomes. Drug Metab Dipos 21:1147-1150.
3. Chou KH, Flores S and Jungalwala FB (1991) Expression and regulation of UDP-glucuronate: Neolactotetraosylceramide glucuronosyltransferase in the nervous system. J Biol Chem 266: 17941-17947.
4. Coughtrie M, Burchell B, Leakey JEA and Hume R (1988) The inadequacy of perinatal glucuronidation: Immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol Pharmacol 34:729-735.
5. Dragacci S, Thomassin J, Magdalou J, Souhaili El Amri H, Boissel P and Siest G (1987) Properties of human hepatic UDP-glucuronosyltransferases: Relationship to other inducible enzymes in patients with cholestasis. Eur J Clin Pharmacol 32:485-491.
6. Fournel S, Magdalou J, Pinon P and Siest G (1987) Differential induction profile of drug-metabolizing enzymes after treatment with hypolipidaemic agents. Xenobiotica 17:445-457.
7. Fournel-Gigleux S, Shepherd SRP, Carré MC, Burchell B, Siest G and Caubère P (1989) Novel inhibitors and substrates of bilirubin: UDP-glucuronosyltransferase arylalkylcarboxylic acids. Eur J Biochem 183:653-659
8. Fournel-Gigleux S, Sutherland L, Sabolovic N, Burchell B and Siest G (1991) Stable expression of two human UDP-glucuronosyltransferase cDNA in V79 cell cultures. Mol Pharmacol 390:177-183.
9. Guengerich FP, Parikh A, Johnson EF, Richardson TH, von Wachenfeldt C, Cosme J, Jung F, Strassburg CP, Manns MP, Tukey RH, Pritchard M, Fournel-Gigleux S and Burchell B (1997) Heterologous expression of human drug-metabolizing enzymes. Drug Metab Dispos 25:1234-1241.
10. Haumont M, Magdalou J, Lafaurie C, Ziegler JM., Siest G and Colin JN (1990) Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3′-azido-3′-deoxythymidine (AZT). Characterization of the enzyme in human and rat liver microsomes. Arch Biochem Biophys 281:264-270.
11. Herber R, Hercelin B, Van Cantfort J, De Graeve J, Fournel-Gigleux S, Taguchi T and Magdalou J (1995) Reduction and glucuronidation of naftazone by human and rat liver microsomes. Drug Metab Dispos 23:1305-1314.
12. Hogeboom GH (1955) Fractionation of cells components of animal tissues: General method for isolation of liver cells components. Methods Enzymol 1:16-19.
13. Huskey SW, Magdalou J, Ouzzine M, Siest G and Chiu SHL (1994) N-glucuronidation reactions. III. Regioselectivity of N-glucuronidation of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole using human and rat recombinant UDP-glucuronosyltransferase stably expressed in V79 cells. Drug Metab Dispos 22:659-662.
14. Jin CJ, Mackenzie PI and Miners J (1997) The regio-and stereo-selectivity of C19 and C21 hydroxysteroid glucuronidation by UGT2B7 and UGT2B11. Arch Biochem Biophys 341:207-211.
15. Jin CJ, Miners JO, Lillywhite KJ and Mackenzie PI (1993) cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily. Biochem Biophys Res Commun 194:496-503.
16. Kitagawa H, Tone Y, Tamura J, Neumann KW, Ogawa T, Oka S, Kawasaki T and Sugahara K (1998) Molecular cloning and expression of glucuronosyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans. J Biol Chem 273: 6615-6618.
17. Lacarelle B, Rajaonarison JF, Catalin J, Durand A and Cano JP (1993) UDP-glucuronosyltransferase activity toward digitoxigenin monodigitoxoside in human liver microsomes. Drug Metab Dispos 21:338-341.
18. Lidholt K and Lindahl U (1992) Biosynthesis of heparin. The D-glucuronosyl-and N-acetyl-D-glucosaminyltransferase reactions and their relation to polymer modification. Biochem J 287:21-29.
19. Little JM, Lehman PA, Nowell S, Samokyszyn V and Radominska A (1997) Glucuronidation of all-trans-retinoic acid and 5,6-epoxy-all-trans-retinoic acid. Activation of rat liver microsomal UDP-glucuronosyltransferase activity by alamethicin. Drug Metab Dispos 25:5-11.
20. Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairocli A, Belanger A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, Lancet D, Louisot P, Magdalou J, Roy-Chowdhury J, Ritter JK, Schachter H, Tephly TR, Tipton KK and Nebert DW (1997) The UDP glycosyltransferase gene superfamily: Recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255-269.
21. Magdalou J, Chajes V, Lafaurie C and Siest G (1990) Glucuronidation of 2-arylpropionic acids pirprofen, flurbiprofen, and ibuprofen by liver microsomes. Drug Metab Dispos 18:692-697.
22. Magdalou J, Fournel-Gigleux S, Goudonnet H, Pritchard M and Siest G (1994) UDP-glucuronosyltransferases and peroxisomes proliferators, in Peroxisome Proliferators: Unique Inducers of Drug Metabolizing Enzymes (Moody D ed) pp 79-95, CRC Press, Inc., Boca Raton.
23. Magdalou J, Herber R, Bidault R and Siest G (1992) In vitro N-glucuronidation of a novel antiepileptic drug lamotrigine by human liver microsomes. J Pharmacol Exp Ther 260:1166-1173.
24. Martin NB, Masson P, Sepulchre C, Theveniaux J, Millet J and Bellamy F (1996) Pharmacological and biochemical profiles of new venous antithrombotic beta-D-xyloside derivatives: Potential antiathero/thrombotic drugs. Semin Thromb Hemostasis 22:247-254.
25. Neben DW (1991) Proposed role of drug-metabolizing enzymes: Regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. Mol Endocrinol 5:1203-1214.
26. Okulicz-Kozaryn I, Schaeffer M, Batt AM, Siest G and Loppinet V (1981) Stereochemical heterogeneity of hepatic UDP-glucuronosyltransferase activity in rat liver microsomes. Biochem Pharmacol 30:1457-1461.
27. Ouzzine M, Pillot T, Fournel-Gigleux S, Magdalou J, Burchell B and Siest G (1994) Expression and role of the human liver UDP-glucuronosyltransferase UGT1*6 analyzed by specific antibodies raised against a hybrid protein produced in Escherichia coli. Arch Biochem Biophys 310:96-304.
28. Patanella JE, Walsh JS, Unger SE, Miwa GT, Parry PS, Daniel MJ and Evans GL (1990) Identification of a glucuronide conjugate of the carbocyclic nucleoside, carbovir, isolated from marmoset urine. Drug Metab Dispos 18:1092-1095.
29. Pillot T, Ouzzine M, Fournel-Gigleux S, Lafaurie C, Radominska A, Burchell B, Siest G and Magdalou J (1993) Glucuronidation of hyodeoxycholic acid in human liver: Evidence for a selective role of UDP-glucuronosyltransferase 2B4. J Biol Chem 268:25636-25642.
30. Pritchard M, Fournel-Gigleux S, Siest G, Mackenzie P and Magdalou J (1994) A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UGT2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols and carboxylic acids. Mol Pharmacol 45:42-50.
31. Rajaonarison JF, Lacarelle B, De Sousa G, Catalin J and Rahmani R (1991) In vitro glucuronidation of 3′-azido-3′-deoxythymidine by human liver. Role of UDP-glucuronosyltransferase 2 form. Drug Metab Dispos 19:809-815.
32. Remmel RP and Burchell B (1993) Validation and use of cloned, expressed human drug-metabolizing enzymes in heterologous cells for analysis of drug metabolism and drug-drug interactions. Biochem Pharmacol 46:559-566.
33. Said M, Noort D, Magdalou J, Ziegler JC, Van Der Marel GA, Van Boom JH, Mulder GJ and Siest G (1992) Selective and potent inhibitors of different hepatic UDP-glucuronosyltransferase activities by ω,ω,ω-triphenylalcohols and UDP-derivatives. Biochem Biophys Res Commun 187:140-145.
34. Senay C, Ouzzine M, Battaglia E, Pless D, Cano V, Burchell B, Radominska A, Magdalou J and Fournel-Gigleux S (1997) Arginine 52 and histidine 54 located in a conserved N-terminal hydrophobic region (LX2-R52-G-H54-X3-V-L) are important amino acids for the functional and structural integrity of the human liver UDP-glucuronosyltransferase UGT1*6. Mol Pharmacol 51:406-413.